Lv79
3398 积分 2022-03-03 加入
Telitacicept for IgA Nephropathy — Interim Analysis of a Phase 3 Trial
11小时前
求助中
Telitacicept for IgA Nephropathy — Interim Analysis of a Phase 3 Trial
11小时前
已完结
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial
2天前
已完结
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial
2天前
已完结
Results From the Phase III Randomized Trial of Onartuzumab Plus Erlotinib Versus Erlotinib in Previously Treated Stage IIIB or IV Non–Small-Cell Lung Cancer: METLung
7天前
已完结
Tiragolumab Plus Atezolizumab and Chemotherapy for Advanced Nonsquamous Non–Small Cell Lung Cancer
11天前
已关闭
Long-Term Impact of First-Line Amivantamab Plus Lazertinib Versus Osimertinib on Mechanisms of Acquired Resistance in MARIPOSA: A Brief Report
11天前
已关闭
Long-Term Impact of First-Line Amivantamab Plus Lazertinib Versus Osimertinib on Mechanisms of Acquired Resistance in MARIPOSA: A Brief Report
11天前
已关闭
CD19 CAR T-Cell Therapy for Treatment of Chronic Graft-versus-Host Disease
11天前
已完结
Tiragolumab Plus Atezolizumab and Chemotherapy for Advanced Nonsquamous Non–Small Cell Lung Cancer
11天前
已完结
皖公网安备34019202002308
